Basic Subscription

Screening & due diligence tools powered by AI, including Investment Risk Score, valuation prediction, Digital Footprint Analysis, legal & financial due diligence, competition analysis and Team Diversity Score

Premium Subscription

Full due diligence reports including detailed market analysis, team, legal and financial due diligence by experienced analysts augmented with AI

Startup Diagnostics

Check your investor-readiness, receive due diligence checklist and consultation to save time and hassle. Special discount for female founders

AI technology

for venture investment

V
VentureFlow helps venture investors mitigate risk, save time and labor by augmenting due diligence with AI.
We vet and list the best portfolio companies for venture capitalists, private equity, angel investors, funds, incubators and our own venture fund. 
We have built a machine learning algorithm to predict the survival rate of a startup, as the basis of our Investment Risk Score.
For team due diligence, our deep learning prototype aggregates and analyzes founder digital footprint using natural language processing (NLP) and convolutional neural network (CNN).

Know-Your-Portfolio KYP System



for faster smarter screening & due diligence

The KYP System is VentureFlow’s screening and due diligence framework for venture investment.
It disrupts the risk capital industry by helping venture investors make higher returns, as well as help professional analysts save time and labor.
We are applying worldwide patent for the KYP System.
Roadmap 2019 / 2020

market Strategy & development Milestones

Core Team

Website_Bild
Xiao Jean Chen
Founder Execution
  • Blockchain Investor
  • Management consultant in 5G Zurich & Hong Kong
  • Google developer scholar
  • PhD in Organizational Management at University of Zurich

 

rwoHxKqFSfmCr1n3Mpn5yA_thumb_b7d
Kuldeep Singh
Business Development
  • Founded Singh Asset Management
  • Consulted client portfolio at Merrill Lynch
  • Held director & investment committee member positions at several investment funds
my_photo
Kamal Azzaoui
Health Tech
  • Drug researcher at Novartis
  • Cofounder of Saverna Therapeutics
  • PhD in Computational Chemistry from Université d’Orléans

 

Mei
Jie Mei
Artificial Intelligence
  • Robotics World Championship referee
  • German Federal Institute of Risk Assessment researcher
  • PhD in computational neuroscience from Charité
0-2
Daniel Biesuz
Advisor Legal
0
Tarry Singh
Advisor AI
0-3
Nathalie Feingold
Advisor Risk
0
Yauhen Klimovich
Advisor NLP
mark_11-e1441695481334
Mark Nelson
Advisor Investment

clients

& awards

Question?

We’ll get in touch ASAP!

Receive perks & updates!

Newsletter

Office

Förrlibuckstrasse 10

8005 Zürich

Switzerland

follow

contact